Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: Rick Costantino who wrote (3436)	1/13/1998 3:17:00 PM
From: Jonathan Schonsheck	Respond to of 4342

Rick - From the PRLN Home Page/Press Releases PARACELSIAN, INC. ANNOUNCES EXTENSION OF OUTSTANDING WARRANTS ON COMMON STOCK ITHACA, NY, March 27, 1997-Paracelsian, Inc. (NASDAQ: PRLN) announced today that its Board of Directors has approved an extension of the warrants for Common Stock through September 6, 1998. The warrants, which were a dividend in September 1993, were scheduled to expire on September 6, 1997. Each warrant entitles the holder to purchase one share of Common Stock at a price of $3.25. The Company can redeem the warrants if the sales price of the Common Stock exceeds $4.75 for 15 consecutive days. Any warrants not redeemed prior to September 6, 1998 will lapse. Paracelsian is a biotechnology company engaged in the discovery of useful products from herbal sources. Its discoveries are accomplished by applying the Company's proprietary screening technology, based in signal transduction, to its library of extracts used in Traditional Chinese Medicine.